Resverlogix Notice of Conference Call & Webcast

About this update from Resverlogix Corp.

[{"type":"text","content":"\n\n\n\nTSX Exchange Symbol: RVX\n\n\nCALGARY, Aug. 21 /CNW/ - Resverlogix Corp. ("Resverlogix") (TSX:RVX) is\npleased to announce that it will host a live teleconference on August 25, 2008\nat 11:00 am MDT to provide a corporate update of the Company. Following the\npresentation there will be a live question and answer session.\n\n\nThe webcast can be accessed at the following link:\n\n\nhttp://services.choruscall.com/links/resverlogix080825.html\n\n\nParticipants can also dial in for the conference call:\nDial information is as follows:\nNorth American Toll Free Dial In: 1-800-319-4610\nInternational Dial In: +1-604-638-5340\n\n\nThe webcast will be available on the Resverlogix website for replay for a\nperiod of 10 days after the event.\n\n\nAbout Resverlogix Corp.\n\n\nResverlogix Corp. is a leading biotechnology company engaged in the\ndevelopment of novel therapies for important global medical markets with\nsignificant unmet needs. The NexVas(TM) program is the Company's primary focus\nwhich is to develop novel small molecules that enhance ApoA-I. These vital\ntherapies address the grievous burden of atherosclerosis and other important\ndiseases such as acute coronary syndrome, diabetes, Alzheimer's and other\nvascular disorders. The Company's secondary focus is TGF-Beta Shield(TM), a\nprogram that aims to address burgeoning grievous diseases, such as cancer and\nfibrosis. Resverlogix Corp. trades on the Toronto Stock Exchange (TSX:RVX).\nFor further information please visit www.resverlogix.com.\n\n\nThis news release may contain certain forward-looking statements that\nreflect the current views and/or expectations of Resverlogix Corp. with\nrespect to its performance, business and future events. Such statements are\nsubject to a number of risks, uncertainties and assumptions. Actual results\nand events may vary significantly. The TSX Exchange does not accept\nresponsibility for the adequacy or accuracy of this news release.\n\n\n%SEDAR: 00019253E\n\n\n","length":2109,"tagName":"div"}]

More updates from Resverlogix Corp.